Descripción del Producto
Antineoplásico Inyección de doxorrubicina 10 ml: 20 mg can be used as First-line of systemic chemotherapy drugs or as second-line chemotherapy drugs for treatment with progression of AIDS-KS patients, also can be used to can’t tolerate the following more than two drug combination chemotherapy patients: vincristine, bleomycin and doxorubicin. Inyección antineoplásica de doxorrubicina can be used for low CD4 (3) and has a broad visceral disease of skin mucosa viscera and related to HIV/AIDS AIDS – KS patients.
Nombre del medicamento
Nombre generico. Inyección de liposomas de clorhidrato de doxorrubicina
Nombre inglés. Inyección de liposomas de clorhidrato de doxorrubicina
Molecular Formular. C27H29NO11 HCl
Peso molecular. 579,99
Inyección antineoplásica de doxorrubicina Descripción
This product is red semitransparent mixed suspension.
Inyección antineoplásica de doxorrubicina Indicaciones
1. This product can be used for low CD4 (3) and has a broad visceral disease of skin mucosa viscera and related to HIV/AIDS AIDS – KS patients.
2. This product can be used as First-line of systemic chemotherapy drugs or as second-line chemotherapy drugs for treatment with progression of AIDS-KS patients, also can be used to can’t tolerate the following more than two drug combination chemotherapy patients:vincristine, bleomycin and doxorubicin (or other anthracycline antibióticos).
Especificación
20 mg/ 10 ml
embalaje
1 botella/caja
Preparativos
inyección
